30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Mirum Pharmaceuticals Inc (MIRM)

Track

Over the last 90 days, Mirum Pharmaceuticals Inc. has seen significant insider selling, with total sales exceeding $9 million. Notably, the CEO and CFO have been active sellers, with multiple planned and proposed sales. No insider purchases were recorded during this period. The stock has experienced a 15.3% increase in the last 90 days.
Stock chart
Ticker: MIRM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Howe Jolanda
SVP, GLOBAL CONTROLLER
1 sale — total 100,000 USD
Planned sale 17 Jun 2026
Value US$238,726.50 | Price 415.11 | Shares 40,362
Proposed sale 17 Jun 2026
Value US$2,178,718.63 | Price 41.88 | Shares 24,001
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 95.12 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 93.95 | Shares 1,000
Planned sale 8 Jun 2026
Value US$100,000.00 | Price 92.84 | Shares 1,000
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 93.81 | Shares 1,000
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 93.81 | Shares 1,000
Planned sale 1 Jun 2026
Value US$397,700.00 | Price 100.00 | Shares 3,977
Planned sale 1 Jun 2026
Value US$87,999.78 | Price 99.66 | Shares 883
Planned sale 1 Jun 2026
Value US$100,262.20 | Price 98.20 | Shares 1,021
Planned sale 1 Jun 2026
Value US$192,485.88 | Price 97.56 | Shares 1,973
Planned sale 1 Jun 2026
Value US$665,934.90 | Price 96.15 | Shares 6,926
Planned sale 1 Jun 2026
Value US$1,582,167.30 | Price 95.34 | Shares 16,595
Planned sale 1 Jun 2026
Value US$246,253.28 | Price 94.64 | Shares 2,602
Proposed sale 1 Jun 2026
Value US$2,875,107.00 | Price 95.84 | Shares 30,000
Proposed sale 1 Jun 2026
Value US$397,700.00 | Price 100.00 | Shares 3,977
Planned sale 15 May 2026
Value US$218,940.00 | Price 109.47 | Shares 2,000
Proposed sale 15 May 2026
Value US$218,940.00 | Price 109.47 | Shares 2,000
Planned sale 15 Apr 2026
Value US$193,800.00 | Price 96.90 | Shares 2,000
Proposed sale 15 Apr 2026
Value US$193,800.00 | Price 96.90 | Shares 2,000
Sale 16 Mar 2026
Value US$670,242.96 | Price 91.98 | Shares 7,287
Sale 16 Mar 2026
Value US$435,239.42 | Price 91.98 | Shares 4,732
Sale 16 Mar 2026
Value US$3,769,714.23 | Price 91.98 | Shares 40,985
Sale 16 Mar 2026
Value US$1,519,015.02 | Price 91.98 | Shares 16,515
Planned sale 16 Mar 2026
Value US$181,520.00 | Price 90.76 | Shares 2,000
Sale 16 Mar 2026
Value US$670,242.96 | Price 91.98 | Shares 7,287
Proposed sale 16 Mar 2026
Value US$675,067.68 | Price 92.64 | Shares 7,287
Proposed sale 16 Mar 2026
Value US$675,067.68 | Price 92.64 | Shares 7,287
Proposed sale 16 Mar 2026
Value US$1,529,949.60 | Price 92.64 | Shares 16,515
Proposed sale 16 Mar 2026
Value US$438,372.48 | Price 92.64 | Shares 4,732
Proposed sale 16 Mar 2026
Value US$3,796,850.40 | Price 92.64 | Shares 40,985
Proposed sale 16 Mar 2026
Value US$181,520.00 | Price 90.76 | Shares 2,000
Planned sale 13 Feb 2026
Value US$204,180.00 | Price 102.09 | Shares 2,000
Proposed sale 13 Feb 2026
Value US$204,180.00 | Price 102.09 | Shares 2,000
Sale 2 Feb 2026
Value US$99,997.79 | Price 103.30 | Shares 968
Sale 2 Feb 2026
Value US$99,997.79 | Price 103.30 | Shares 968
Sale 2 Feb 2026
Value US$271,791.51 | Price 103.30 | Shares 2,631
Sale 2 Feb 2026
Value US$940,888.28 | Price 103.30 | Shares 9,108
Proposed sale 2 Feb 2026
Value US$100,478.40 | Price 103.80 | Shares 968
Proposed sale 2 Feb 2026
Value US$273,097.80 | Price 103.80 | Shares 2,631
Proposed sale 2 Feb 2026
Value US$945,410.40 | Price 103.80 | Shares 9,108
Proposed sale 26 Jan 2026
Value US$81,606.64 | Price 96.92 | Shares 842
Proposed sale 26 Jan 2026
Value US$304,619.56 | Price 96.92 | Shares 3,143
Proposed sale 26 Jan 2026
Value US$662,060.52 | Price 96.92 | Shares 6,831
Proposed sale 26 Jan 2026
Value US$102,056.76 | Price 96.92 | Shares 1,053
Sale 26 Jan 2026
Value US$657,087.55 | Price 96.19 | Shares 6,831
Sale 26 Jan 2026
Value US$101,290.18 | Price 96.19 | Shares 1,053
Sale 26 Jan 2026
Value US$80,993.66 | Price 96.19 | Shares 842
Sale 26 Jan 2026
Value US$302,331.46 | Price 96.19 | Shares 3,143
Buy 23 Jan 2026
Value US$8,999,984.00 | Price 68.48 | Shares 131,425
Sale 22 Jan 2026
Value US$170,038.51 | Price 93.33 | Shares 1,822
Sale 22 Jan 2026
Value US$662,422.27 | Price 93.33 | Shares 7,098
Sale 22 Jan 2026
Value US$86,419.14 | Price 93.33 | Shares 926
Sale 22 Jan 2026
Value US$132,615.11 | Price 93.33 | Shares 1,421
Sale 22 Jan 2026
Value US$222,300.63 | Price 93.33 | Shares 2,382
Sale 20 Jan 2026
Value US$623,853.21 | Price 90.27 | Shares 6,911
Planned sale 15 Jan 2026
Value US$181,980.00 | Price 90.99 | Shares 2,000
Proposed sale 15 Jan 2026
Value US$181,980.00 | Price 90.99 | Shares 2,000
Planned sale 22 Dec 2025
Value US$400,000.00 | Price 80.00 | Shares 5,000
Proposed sale 22 Dec 2025
Value US$400,000.00 | Price 80.00 | Shares 5,000
Planned sale 19 Dec 2025
Value US$3,900,000.00 | Price 78.00 | Shares 50,000
Proposed sale 19 Dec 2025
Value US$3,900,000.00 | Price 78.00 | Shares 50,000
Planned sale 18 Dec 2025
Value US$70,000.00 | Price 70.00 | Shares 1,000
Planned sale 18 Dec 2025
Value US$69,460.00 | Price 69.46 | Shares 1,000
Proposed sale 18 Dec 2025
Value US$139,460.00 | Price 69.73 | Shares 2,000
Planned sale 1 Dec 2025
Value US$3,700,000.00 | Price 74.00 | Shares 50,000
Proposed sale 1 Dec 2025
Value US$3,700,000.00 | Price 74.00 | Shares 50,000
Planned sale 21 Nov 2025
Value US$3,500,000.00 | Price 70.00 | Shares 50,000
Proposed sale 21 Nov 2025
Value US$3,500,000.00 | Price 70.00 | Shares 50,000
Sale 12 Sep 2025
Value US$728,023.78 | Price 76.01 | Shares 9,578
Sale 11 Sep 2025
Value US$111,929.37 | Price 75.07 | Shares 1,491
Sale 11 Sep 2025
Value US$1,152,939.06 | Price 74.34 | Shares 15,509
Proposed sale 11 Sep 2025
Value US$1,264,917.30 | Price 74.41 | Shares 17,000
Proposed sale 8 Sep 2025
Value US$1,309,715.70 | Price 77.04 | Shares 17,000
Planned sale 11 Aug 2025
Value US$2,480,000.00 | Price 62.00 | Shares 40,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17 PlS Planned sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
40,362 -37.1%
415.11
US$238,727 		40,362 -37.1% 415.11 US$238,727
2026-06-17 2026-06-17 PrS Proposed sale
2.9
JOLANDA MARIE HOWE

Officer

Officer
24,001
41.88
US$2,178,719 		24,001 41.88 US$2,178,719
2026-06-09 2026-06-08 PlS Planned sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
35,280 -10.1%
229.55
US$2,017,089 		35,280 -10.1% 229.55 US$2,017,089
2026-06-09 2026-06-08 PlS Planned sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,000 -2.5%
93.95
US$100,000 		1,000 -2.5% 93.95 US$100,000
2026-06-09 2026-06-08 PlS Planned sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,000 -4.5%
92.84
US$100,000 		1,000 -4.5% 92.84 US$100,000
2026-06-08 2026-06-08 PrS Proposed sale
3.3
ERIC BJERKHOLT

Officer

Officer
1,000
93.81
US$100,000 		1,000 93.81 US$100,000
2026-06-08 2026-06-08 PrS Proposed sale
3.3
ERIC BJERKHOLT

Officer

Officer
1,000
93.81
US$100,000 		1,000 93.81 US$100,000
2026-06-02 2026-06-01 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
3,977 -100.0%
100.00
US$397,700 		3,977 -100.0% 100.00 US$397,700
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
883 -0.5%
99.66
US$88,000 		883 -0.5% 99.66 US$88,000
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
1,021 -0.5%
98.20
US$100,262 		1,021 -0.5% 98.20 US$100,262
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
1,973 -1.0%
97.56
US$192,486 		1,973 -1.0% 97.56 US$192,486
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
6,926 -3.4%
96.15
US$665,935 		6,926 -3.4% 96.15 US$665,935
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
16,595 -7.5%
95.34
US$1,582,167 		16,595 -7.5% 95.34 US$1,582,167
2026-06-02 2026-06-01 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
2,602 -1.2%
94.64
US$246,253 		2,602 -1.2% 94.64 US$246,253
2026-06-01 2026-06-01 PrS Proposed sale
3.4
CHRISTOPHER PEETZ

Officer; Director

Executive Director
30,000
95.84
US$2,875,107 		30,000 95.84 US$2,875,107
2026-06-01 2026-06-01 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
3,977
100.00
US$397,700 		3,977 100.00 US$397,700
2026-05-18 2026-05-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
109.47
US$218,940 		2,000 -100.0% 109.47 US$218,940
2026-05-15 2026-05-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
109.47
US$218,940 		2,000 109.47 US$218,940
2026-04-16 2026-04-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
96.90
US$193,800 		2,000 -100.0% 96.90 US$193,800
2026-04-15 2026-04-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
96.90
US$193,800 		2,000 96.90 US$193,800
2026-03-17 2026-03-16 S Sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
7,287 -12.8%
91.98
US$670,243 		7,287 -12.8% 91.98 US$670,243
2026-03-17 2026-03-16 S Sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
4,732 -36.0%
91.98
US$435,239 		4,732 -36.0% 91.98 US$435,239
2026-03-17 2026-03-16 S Sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
40,985 -17.4%
91.98
US$3,769,714 		40,985 -17.4% 91.98 US$3,769,714
2026-03-17 2026-03-16 S Sale
2.8
Radovich Peter

PRESIDENT AND COO

Officer
16,515 -29.1%
91.98
US$1,519,015 		16,515 -29.1% 91.98 US$1,519,015
2026-03-17 2026-03-16 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
90.76
US$181,520 		2,000 -100.0% 90.76 US$181,520
2026-03-17 2026-03-16 S Sale
1.9
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
7,287 -27.9%
91.98
US$670,243 		7,287 -27.9% 91.98 US$670,243
2026-03-17 2026-03-16 PrS Proposed sale
3.3
ERIC BJERKHOLT

Officer

Officer
7,287
92.64
US$675,068 		7,287 92.64 US$675,068
2026-03-17 2026-03-16 PrS Proposed sale
1.9
Joanne Quan

Officer

Officer
7,287
92.64
US$675,068 		7,287 92.64 US$675,068
2026-03-17 2026-03-16 PrS Proposed sale
2.8
Peter Radovich

Officer

Officer
16,515
92.64
US$1,529,950 		16,515 92.64 US$1,529,950
2026-03-17 2026-03-16 PrS Proposed sale
2.9
Jolanda Howe

Officer

Officer
4,732
92.64
US$438,372 		4,732 92.64 US$438,372
2026-03-17 2026-03-16 PrS Proposed sale
3.4
Christopher Peetz

Officer; Director

Executive Director
40,985
92.64
US$3,796,850 		40,985 92.64 US$3,796,850
2026-03-16 2026-03-16 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
90.76
US$181,520 		2,000 90.76 US$181,520
2026-02-17 2026-02-13 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
102.09
US$204,180 		2,000 -100.0% 102.09 US$204,180
2026-02-13 2026-02-13 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
102.09
US$204,180 		2,000 102.09 US$204,180
2026-02-03 2026-02-02 S Sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
968 -17.7%
103.30
US$99,998 		968 -17.7% 103.30 US$99,998
2026-02-03 2026-02-02 S Sale
2.8
Radovich Peter

PRESIDENT AND COO

Officer
2,631 -11.3%
103.30
US$271,792 		2,631 -11.3% 103.30 US$271,792
2026-02-03 2026-02-02 S Sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
9,108 -5.4%
103.30
US$940,888 		9,108 -5.4% 103.30 US$940,888
2026-02-03 2026-02-02 S Sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
968 -17.7%
103.30
US$99,998 		968 -17.7% 103.30 US$99,998
2026-02-02 2026-02-02 PrS Proposed sale
2.9
Jolanda Howe

Officer

Officer
968
103.80
US$100,478 		968 103.80 US$100,478
2026-02-02 2026-02-02 PrS Proposed sale
2.8
Peter Radovich

Officer

Officer
2,631
103.80
US$273,098 		2,631 103.80 US$273,098
2026-02-02 2026-02-02 PrS Proposed sale
3.4
Christopher Peetz

Officer; Director

Executive Director
9,108
103.80
US$945,410 		9,108 103.80 US$945,410
2026-01-28 2026-01-26 PrS Proposed sale
2.9
Jolanda Howe

Officer

Officer
842
96.92
US$81,607 		842 96.92 US$81,607
2026-01-28 2026-01-26 PrS Proposed sale
2.8
Peter Radovich

Officer

Officer
3,143
96.92
US$304,620 		3,143 96.92 US$304,620
2026-01-28 2026-01-26 PrS Proposed sale
3.4
Christopher Peetz

Officer; Director

Executive Director
6,831
96.92
US$662,061 		6,831 96.92 US$662,061
2026-01-28 2026-01-26 PrS Proposed sale
3.3
ERIC BJERKHOLT

Officer

Officer
1,053
96.92
US$102,057 		1,053 96.92 US$102,057
2026-01-27 2026-01-26 S Sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
6,831 -3.9%
96.19
US$657,088 		6,831 -3.9% 96.19 US$657,088
2026-01-27 2026-01-26 S Sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,053 -2.4%
96.19
US$101,290 		1,053 -2.4% 96.19 US$101,290
2026-01-27 2026-01-26 S Sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
842 -18.5%
96.19
US$80,994 		842 -18.5% 96.19 US$80,994
2026-01-27 2026-01-26 S Sale
2.8
Radovich Peter

PRESIDENT AND COO

Officer
3,143 -11.9%
96.19
US$302,331 		3,143 -11.9% 96.19 US$302,331
2026-01-27 2026-01-23 B Purchase
3.8
Heron Patrick J
Non-Executive Director
131,425 +40.1%
68.48
US$8,999,984 		131,425 +40.1% 68.48 US$8,999,984
2026-01-23 2026-01-22 S Sale
1.9
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
1,822 -12.4%
93.33
US$170,039 		1,822 -12.4% 93.33 US$170,039
2026-01-23 2026-01-22 S Sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
7,098 -4.2%
93.33
US$662,422 		7,098 -4.2% 93.33 US$662,422
2026-01-23 2026-01-22 S Sale
2.9
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
926 -23.3%
93.33
US$86,419 		926 -23.3% 93.33 US$86,419
2026-01-23 2026-01-22 S Sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,421 -3.3%
93.33
US$132,615 		1,421 -3.3% 93.33 US$132,615
2026-01-23 2026-01-22 S Sale
2.8
Radovich Peter

PRESIDENT AND COO

Officer
2,382 -10.3%
93.33
US$222,301 		2,382 -10.3% 93.33 US$222,301
2026-01-21 2026-01-20 S Sale
1.9
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
6,911 -37.9%
90.27
US$623,853 		6,911 -37.9% 90.27 US$623,853
2026-01-16 2026-01-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
90.99
US$181,980 		2,000 -100.0% 90.99 US$181,980
2026-01-15 2026-01-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
90.99
US$181,980 		2,000 90.99 US$181,980
2025-12-23 2025-12-22 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
5,000 -100.0%
80.00
US$400,000 		5,000 -100.0% 80.00 US$400,000
2025-12-22 2025-12-22 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
5,000
80.00
US$400,000 		5,000 80.00 US$400,000
2025-12-23 2025-12-19 PlS Planned sale
1.1
GREY MICHAEL G
Non-Executive Director
50,000 -100.0%
78.00
US$3,900,000 		50,000 -100.0% 78.00 US$3,900,000
2025-12-19 2025-12-19 PrS Proposed sale
1.1
MICHAEL GREY

Director

Non-Executive Director
50,000
78.00
US$3,900,000 		50,000 78.00 US$3,900,000
2025-12-19 2025-12-18 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
1,000 -100.0%
70.00
US$70,000 		1,000 -100.0% 70.00 US$70,000
2025-12-19 2025-12-18 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
1,000 -50.0%
69.46
US$69,460 		1,000 -50.0% 69.46 US$69,460
2025-12-18 2025-12-18 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
69.73
US$139,460 		2,000 69.73 US$139,460
2025-12-02 2025-12-01 PlS Planned sale
1.1
GREY MICHAEL G
Non-Executive Director
50,000 -100.0%
74.00
US$3,700,000 		50,000 -100.0% 74.00 US$3,700,000
2025-12-01 2025-12-01 PrS Proposed sale
1.1
MICHAEL GREY

Director

Non-Executive Director
50,000
74.00
US$3,700,000 		50,000 74.00 US$3,700,000
2025-11-25 2025-11-21 PlS Planned sale
1.1
GREY MICHAEL G
Non-Executive Director
50,000 -100.0%
70.00
US$3,500,000 		50,000 -100.0% 70.00 US$3,500,000
2025-11-21 2025-11-21 PrS Proposed sale
1.1
MICHAEL GREY

Director

Non-Executive Director
50,000
70.00
US$3,500,000 		50,000 70.00 US$3,500,000
2025-09-12 2025-09-12 S Sale
3.3
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
9,578 -19.3%
76.01
US$728,024 		9,578 -19.3% 76.01 US$728,024
2025-09-12 2025-09-11 S Sale
3.1
Brege Laura
Non-Executive Director
1,491 -8.7%
75.07
US$111,929 		1,491 -8.7% 75.07 US$111,929
2025-09-12 2025-09-11 S Sale
3.1
Brege Laura
Non-Executive Director
15,509 -47.4%
74.34
US$1,152,939 		15,509 -47.4% 74.34 US$1,152,939
2025-09-11 2025-09-11 PrS Proposed sale
3.1
LAURA BREGE

Director

Non-Executive Director
17,000
74.41
US$1,264,917 		17,000 74.41 US$1,264,917
2025-09-08 2025-09-08 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
17,000
77.04
US$1,309,716 		17,000 77.04 US$1,309,716
2025-08-12 2025-08-11 PlS Planned sale
3.4
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
40,000 -22.4%
62.00
US$2,480,000 		40,000 -22.4% 62.00 US$2,480,000
Explore more

More insider trading research around Mirum Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America